Literature DB >> 30235938

Exosomal miR-1246 in body fluids is a potential biomarker for gastrointestinal cancer.

Chunmeng Wei1, Yasi Li2, Kaiming Huang1, Gang Li1, Min He1,3.   

Abstract

AIM: The aim was to systematically evaluate whether exosomal miRNAs could be regarded as potential minimally invasive biomarkers of diagnosis for gastrointestinal cancer.
METHODS: A systematic review and meta analysis of exosomal miRNA expression in gastrointestinal cancer were performed.
RESULTS: A total of 370 articles were retrieved from PubMed and EMBASE. The summary receiver operating characteristic curves of three miRNAs (miR-21, miR-1246 and miR-4644) were drawn, miR-21, miR-1246 and miR-4644 exhibited sensitivities of 0.66, 0.920 and 0.750, respectively; specificities were 0.87, 0.958 and 0.769, respectively; and areas under the curve for discriminating gastrointestinal cancer patients from control subjects were 0.876, 0.969 and 0.827, respectively.
CONCLUSION: Exosome miR-1246 had the highest level of diagnostic efficiency, which indicated that miR-1246 could be a biomarker.

Entities:  

Keywords:  SROC; biomarkers; exosome; gastrointestinal cancer; miR-1246; microRNA

Mesh:

Substances:

Year:  2018        PMID: 30235938     DOI: 10.2217/bmm-2017-0440

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  8 in total

1.  Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.

Authors:  Yuntao Shi; Zhonghong Wang; Xiaojuan Zhu; Ling Chen; Yilan Ma; Jiayan Wang; Xiaozhong Yang; Zheng Liu
Journal:  Int J Clin Oncol       Date:  2019-09-10       Impact factor: 3.402

2.  Radiogenomics predicts the expression of microRNA-1246 in the serum of esophageal cancer patients.

Authors:  Isamu Hoshino; Hajime Yokota; Fumitaka Ishige; Yosuke Iwatate; Nobuyoshi Takeshita; Hiroki Nagase; Takashi Uno; Hisahiro Matsubara
Journal:  Sci Rep       Date:  2020-02-13       Impact factor: 4.379

Review 3.  Exosomal miRNA: Small Molecules, Big Impact in Colorectal Cancer.

Authors:  Valentin Vautrot; Gaëtan Chanteloup; Mohammed Elmallah; Marine Cordonnier; François Aubin; Carmen Garrido; Jessica Gobbo
Journal:  J Oncol       Date:  2019-10-13       Impact factor: 4.375

4.  Extracellular Vesicles from Uterine Aspirates Represent a Promising Source for Screening Markers of Gynecologic Cancers.

Authors:  Gleb O Skryabin; Andrey V Komelkov; Kirill I Zhordania; Dmitry V Bagrov; Svetlana V Vinokurova; Sergey A Galetsky; Nadezhda V Elkina; Darya A Denisova; Adel D Enikeev; Elena M Tchevkina
Journal:  Cells       Date:  2022-03-22       Impact factor: 6.600

5.  Construction and validation of a prognostic risk model for breast cancer based on protein expression.

Authors:  Bo Huang; Xujun Zhang; Qingyi Cao; Jianing Chen; Chenhong Lin; Tianxin Xiang; Ping Zeng
Journal:  BMC Med Genomics       Date:  2022-07-04       Impact factor: 3.622

Review 6.  Angioregulatory microRNAs in Colorectal Cancer.

Authors:  Mohammad Hasan Soheilifar; Michael Grusch; Hoda Keshmiri Neghab; Razieh Amini; Hamid Maadi; Massoud Saidijam; Zhixiang Wang
Journal:  Cancers (Basel)       Date:  2019-12-26       Impact factor: 6.639

7.  Verification of the role of exosomal microRNA in colorectal tumorigenesis using human colorectal cancer cell lines.

Authors:  Gyoung Tae Noh; Jiyun Kwon; Jungwoo Kim; Minhwa Park; Da-Won Choi; Kyung-Ah Cho; So-Youn Woo; Bo-Young Oh; Kang Young Lee; Ryung-Ah Lee
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240

Review 8.  Radiogenomics of gastroenterological cancer: The dawn of personalized medicine with artificial intelligence-based image analysis.

Authors:  Isamu Hoshino; Hajime Yokota
Journal:  Ann Gastroenterol Surg       Date:  2021-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.